IMREX CLOTTING SOLUTION DIN 02299674
Health Canada record
| Active ingredient(s) | BUTYL ALCOHOL 70 MG; SODIUM CHLORIDE 9 MG |
|---|---|
| Dosage form | Solution |
| Route | Intramuscular; Intraperitoneal; Intravenous; Subcutaneous |
| Schedule | ETHICAL |
| Class | Veterinary |
| ATC | |
| Original market date | 19-Nov-2008 |
| Current status date | 04-Jul-2022 |
| Source | Health Canada DPD |
Establishment licence of the holder
imRex Inc. — licence 101694, currently licensed, last inspection rating C (2023-08-01).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing BUTYL ALCOHOL
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00225797 | CLOTOL LIQ | PFIZER CANADA INC ANIMAL HEALTH GROUP | Liquid | BUTYL ALCOHOL 7.0 %; SODIUM CHLORIDE 0.9 % | Cancelled Post Market |
International API supply for BUTYL ALCOHOL
0 active FDA Drug Master Files.
Request a quote for IMREX CLOTTING SOLUTION